BCRX

BCRX CapEx to Revenue

0.29%TTM

Retrieved:

BCRX FY CapEx/Revenue%
BCRX FY CapEx/Revenue5257.13%-563.07%
1994-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

BCRX capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 32 observations from Dec 31, 1994 to Dec 31, 2025.

Biocryst Pharmaceuticals Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.2821%
0.2494%
0.6542%
0.4988%
1.5175%
2.8857%
0.7024%
1.7721%
1.3023%
20.0243%
10.614%
0.779%
0.1731%
0.4298%
0.28%
0.5114%
0.8094%
2.1433%
4,693.8876%
24.7054%
327.447%
81.8991%
3.1824%
22.9853%
23.3417%
82.136%
40%
6.25%
110%
11.1111%
100%
57.1429%

Compare capex to revenue

All BCRX financial metrics · BCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.